Stocksigma LogoStocksigma Logo

Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26

Divi's Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated

Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26

Divis Laboratories Ltd 路 Intimation 路 07 Nov 2026, 5:30 am

Divi's Laboratories Schedules Board Meeting for Q2FY27 Results on 7th Nov'26 Divi's Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain shut until 9th Nov'26, concluding 48 hours post-results declaration.

Original exchange filing (PDF)

More announcements from Divis Laboratories Ltd

All Divis Laboratories Ltd announcements